Public Comment from Doctors for America to the Centers for Medicare and Medicaid Services on “Proposed National Coverage Determination for Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer’s Disease” (CAG-00460N)

Prescription Drugs
Doctors for America commends the Centers for Medicare and Medicaid Services (CMS) for their proposed national coverage decision regarding “Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer’s Disease”…
Read Post

Media Inquiries

If you are a news media professional with a question for DFA staff or a member physician, please submit your request using the form below. Please include as much information as possible with your request. All requests will be considered in the order received.

  • This field is for validation purposes and should be left unchanged.
Menu